ClariVest Asset Management’s Transmedics TMDX Stock Holding History

ClariVest Asset Management’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-18,988	Closed	-$1.44M	–	767
2023 Q1	$1.44M	Sell	18,988 -112	-0.6%	-$7.75K	0.06%	223
2022 Q4	$1.18M	Sell	19,100 -200	-1%	-$10.6K	0.06%	251
2022 Q3	$805K	Buy	+19,300	New	+$839K	0.04%	291

Other funds holding TMDX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

SCP

Sandhill Capital Partners Buffalo, New York $1.23B AUM 13.7% 1-Year Est. Return

ClariVest Asset Management's TMDX Position: Q2 2023 in Review

ClariVest Asset Management sold out of Transmedics (TMDX) in Q2 2023, closing a stake of 18,988 shares — an estimated $1.44M sold.

ClariVest Asset Management first reported a position in TMDX in Q3 2022 and held it in 3 quarters. The position peaked at $1.44M in Q1 2023. 240 funds tracked by Wall St. Rank hold TMDX as of Q2 2023.

ClariVest Asset Management reported no remaining Transmedics position as of Q2 2023 after selling out during the quarter.
ClariVest Asset Management sold 18,988 Transmedics shares in Q2 2023, an estimated $1.44M.
ClariVest Asset Management first reported a position in Transmedics in Q3 2022 and held it in 3 quarters.
ClariVest Asset Management's Transmedics position peaked at $1.44M in Q1 2023.
240 funds tracked by Wall St. Rank held Transmedics as of Q2 2023.

Based on ClariVest Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.